Global Rubella Diagnostic Testing Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 27336

Rubella infection generally affects children and adults. This infection has a serious effect on pregnant women and may result in fetal death or congenital defects.
Geographically, the entire rubella diagnostic testing market is classified into North America, Europe, Asia Pacific, Latin America and MEA.
In 2018, the global Rubella Diagnostic Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Rubella Diagnostic Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rubella Diagnostic Testing development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
Beckman Coulter
Bio Rad Laboratories
Biogate Laboratories
BioMerieux SA
Cigna
Diagnostic Laboratory of Oklahoma
GlaxoSmithKline
HealthLink BC
Mayo Clinic
Ortho Clinical Diagnostics
True Health

Market segment by Type, the product can be split into
Flow Cytometry
Latex Slide Agglutination Test
Monoclonal Antibodies
Immunoassays
Serological Testing
Clinical Evaluation

Market segment by Application, split into
Hospitals
Commercial
Physician Offices
Public Health Labs
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Rubella Diagnostic Testing status, future forecast, growth opportunity, key market and key players.
To present the Rubella Diagnostic Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Rubella Diagnostic Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 Flow Cytometry
1.4.3 Latex Slide Agglutination Test
1.4.4 Monoclonal Antibodies
1.4.5 Immunoassays
1.4.6 Serological Testing
1.4.7 Clinical Evaluation
1.5 Market by Application
1.5.1 Global Rubella Diagnostic Testing Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Commercial
1.5.4 Physician Offices
1.5.5 Public Health Labs
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Rubella Diagnostic Testing Market Size
2.2 Rubella Diagnostic Testing Growth Trends by Regions
2.2.1 Rubella Diagnostic Testing Market Size by Regions (2014-2025)
2.2.2 Rubella Diagnostic Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Rubella Diagnostic Testing Market Size by Manufacturers
3.1.1 Global Rubella Diagnostic Testing Revenue by Manufacturers (2014-2019)
3.1.2 Global Rubella Diagnostic Testing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Rubella Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.2 Rubella Diagnostic Testing Key Players Head office and Area Served
3.3 Key Players Rubella Diagnostic Testing Product/Solution/Service
3.4 Date of Enter into Rubella Diagnostic Testing Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Rubella Diagnostic Testing Market Size by Type (2014-2019)
4.2 Global Rubella Diagnostic Testing Market Size by Application (2014-2019)

5 United States
5.1 United States Rubella Diagnostic Testing Market Size (2014-2019)
5.2 Rubella Diagnostic Testing Key Players in United States
5.3 United States Rubella Diagnostic Testing Market Size by Type
5.4 United States Rubella Diagnostic Testing Market Size by Application

6 Europe
6.1 Europe Rubella Diagnostic Testing Market Size (2014-2019)
6.2 Rubella Diagnostic Testing Key Players in Europe
6.3 Europe Rubella Diagnostic Testing Market Size by Type
6.4 Europe Rubella Diagnostic Testing Market Size by Application

7 China
7.1 China Rubella Diagnostic Testing Market Size (2014-2019)
7.2 Rubella Diagnostic Testing Key Players in China
7.3 China Rubella Diagnostic Testing Market Size by Type
7.4 China Rubella Diagnostic Testing Market Size by Application

8 Japan
8.1 Japan Rubella Diagnostic Testing Market Size (2014-2019)
8.2 Rubella Diagnostic Testing Key Players in Japan
8.3 Japan Rubella Diagnostic Testing Market Size by Type
8.4 Japan Rubella Diagnostic Testing Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Rubella Diagnostic Testing Market Size (2014-2019)
9.2 Rubella Diagnostic Testing Key Players in Southeast Asia
9.3 Southeast Asia Rubella Diagnostic Testing Market Size by Type
9.4 Southeast Asia Rubella Diagnostic Testing Market Size by Application

10 India
10.1 India Rubella Diagnostic Testing Market Size (2014-2019)
10.2 Rubella Diagnostic Testing Key Players in India
10.3 India Rubella Diagnostic Testing Market Size by Type
10.4 India Rubella Diagnostic Testing Market Size by Application

11 Central & South America
11.1 Central & South America Rubella Diagnostic Testing Market Size (2014-2019)
11.2 Rubella Diagnostic Testing Key Players in Central & South America
11.3 Central & South America Rubella Diagnostic Testing Market Size by Type
11.4 Central & South America Rubella Diagnostic Testing Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Rubella Diagnostic Testing Introduction
12.1.4 Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Beckman Coulter
12.2.1 Beckman Coulter Company Details
12.2.2 Company Description and Business Overview
12.2.3 Rubella Diagnostic Testing Introduction
12.2.4 Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2014-2019)
12.2.5 Beckman Coulter Recent Development
12.3 Bio Rad Laboratories
12.3.1 Bio Rad Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 Rubella Diagnostic Testing Introduction
12.3.4 Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2014-2019)
12.3.5 Bio Rad Laboratories Recent Development
12.4 Biogate Laboratories
12.4.1 Biogate Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Rubella Diagnostic Testing Introduction
12.4.4 Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2014-2019)
12.4.5 Biogate Laboratories Recent Development
12.5 BioMerieux SA
12.5.1 BioMerieux SA Company Details
12.5.2 Company Description and Business Overview
12.5.3 Rubella Diagnostic Testing Introduction
12.5.4 BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2014-2019)
12.5.5 BioMerieux SA Recent Development
12.6 Cigna
12.6.1 Cigna Company Details
12.6.2 Company Description and Business Overview
12.6.3 Rubella Diagnostic Testing Introduction
12.6.4 Cigna Revenue in Rubella Diagnostic Testing Business (2014-2019)
12.6.5 Cigna Recent Development
12.7 Diagnostic Laboratory of Oklahoma
12.7.1 Diagnostic Laboratory of Oklahoma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Rubella Diagnostic Testing Introduction
12.7.4 Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2014-2019)
12.7.5 Diagnostic Laboratory of Oklahoma Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Details
12.8.2 Company Description and Business Overview
12.8.3 Rubella Diagnostic Testing Introduction
12.8.4 GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2014-2019)
12.8.5 GlaxoSmithKline Recent Development
12.9 HealthLink BC
12.9.1 HealthLink BC Company Details
12.9.2 Company Description and Business Overview
12.9.3 Rubella Diagnostic Testing Introduction
12.9.4 HealthLink BC Revenue in Rubella Diagnostic Testing Business (2014-2019)
12.9.5 HealthLink BC Recent Development
12.10 Mayo Clinic
12.10.1 Mayo Clinic Company Details
12.10.2 Company Description and Business Overview
12.10.3 Rubella Diagnostic Testing Introduction
12.10.4 Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2014-2019)
12.10.5 Mayo Clinic Recent Development
12.11 Ortho Clinical Diagnostics
12.12 True Health

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details